Early Access — free while we kick the tires
EdgarHawk

WOK WORK Medical Technology Group LTD Insider Trading

Latest: Insider Bought $138K of Shares · May 2026

Insider buying has outpaced selling at WORK Medical Technology Group LTD (WOK): 7 buy filings versus 0 sell filings across 1 distinct insider, most recently in Jun 2026. Its highest-significance filing in the last 90 days: HRT Financial LP bought $138K, transaction dated May 2026.

7 filings analyzed · Latest 2026-06-23

Get alerts for WOK

Free Form 4 email alerts, scored for significance — see how.

Buys
7
Sells
0
Insiders
1
Direction
Net buying

Historically, high-priority insider buys have outperformed the S&P 500 by a median ~2% over the 30 days after the trade — the edge is concentrated in that first month (n ≈ 5,579, 2024-2026). Past results don't predict the future. How we measure this ↗

June 2026
2026-06-23
high
880,456 shares
$40,501
@ $0.05
Significance 7

10% owner HRT Financial buys 880,456 shares at $0.05, sells 136,665 at $3.87 same week at WOK

HRT Financial LP, a 10% owner, executed 2 separate transactions at WOK within one trading day: a purchase of 880,456 shares at $0.05 on 2026-06-17 ($40,500.98) and a sale of 136,665 shares at $3.87 on 2026-06-18 ($528,893.55). The 77-fold price differential between the buy and sell tranches in consecutive days is unusual and suggests either distinct lot management or market-driven execution. Post-transaction holdings stand at 123,944 shares, down from a short position of -619,847 shares, representing a net change of 743,791 shares purchased. The stock's price action since the filing date has been severe: a -76.6% 30-day decline and -97.8% 90-day decline from the 52-week high of $930000.00, with current price at $2.62. The insider's prior trades at WOK are clustered tightly in early-to-mid June 2026 (5 trades within a 10-day window), but none have measurable 90-day outcomes yet. This filing warrants examination of the mechanics driving the extreme price dispersion between tranches and the context of the company's market capitalization of $38,230,888.04.

2026-06-17
high
268,927 shares
$25,548
@ $0.09
Significance 7

HRT Financial LP sold 2,904,567 shares at $0.06 on 2026-06-16 while buying 268,927 shares at $0.10 on 2026-06-15, reducing holdings by 87.1%

HRT Financial LP executed 2 separate transactions within the filing: a purchase of 268,927 shares for $25,548.07 and a sale of 2,904,567 shares for $168,464.89. The net effect reduced the 10% owner's stake from 3,027,096 shares to 391,456 shares. The timing is notable: the insider bought at $0.10 on 2026-06-15 and sold at $0.06 on 2026-06-16, the latter occurring after the stock had declined -89.5% over 30 days and -96.5% over 90 days from the 52-week high of $9300.00. At this specific ticker, the insider's prior 5 trades show a 2-of-5 rate of well-timed decisions at the 90-day mark, with a recent pattern of mixed results (buys on 2026-06-01, 2026-06-04, and 2026-06-08 showing -27.5%, -4.8%, and -5.7% 90-day returns respectively). The current price of $0.04 sits at the 52-week low, representing -100.0% from the 52-week high. This substantial reduction in ownership stake during severe price deterioration warrants investor attention to whether this represents a meaningful shift in the 10% owner's conviction.

2026-06-12
medium
3,794,711 shares
$363,500
@ $0.10
Significance 4

HRT Financial LP acquires 3,794,711 shares at WOK for $363,500.43; stock down 100.0% from 52-week high.

HRT Financial LP, a 10% owner, executed 2 separate purchases totaling 3,794,711 shares for $363,500.43 on 2026-06-10 and 2026-06-11 at an blended average price of $0.10, increasing holdings to 2,978,988 shares. The current price of $0.08 reflects a -100.0% decline from the 52-week high and a -97.1% 30-day change, suggesting severe market deterioration at or shortly after these purchase dates. Prior trades by this insider at WOK show mixed results: 4 of 5 prior trades were underwater at 90 days, with only 2 of 5 prior trades well-timed in hindsight. The cross-ticker track record shows 13 prior buys averaging +385.9% 90-day returns, but at this specific ticker the pattern diverges sharply—recent purchases on 2026-06-08, 2026-06-05, and 2026-06-01 all posted negative 90-day returns of -5.7%, +7.5%, and -27.5%, respectively. The discrepancy between strong cross-ticker results and weak WOK-specific outcomes warrants scrutiny of whether market conditions or fundamentals at this ticker have shifted materially.

2026-06-09
high
2,261,118 shares
$239,679
@ $0.11
Significance 2

HRT Financial LP acquired 2,261,118 shares of WOK at $0.11; stock now trades at $0.10, down 92.2% in 30 days from 52-week high of $9300.00.

HRT Financial LP purchased 2,261,118 shares of WORK Medical Technology Group LTD at $0.11 on 2026-06-08, expanding holdings by 585.5% from 386,181 shares to 2,647,299 shares. The current price of $0.10 sits 100.0% below the 52-week high of $9300.00, with the stock declining 92.2% over the past 30 days and 90.9% over 90 days. At the same ticker, HRT's prior buy on 2026-05-28 yielded a 90d return of +15.6%, while a subsequent sell on 2026-05-29 achieved a 90d return of +4.0%—indicating 1 of 2 prior trades was well-timed at the 90-day mark. The transaction occurred in a micro-cap environment (market cap $1.5M), and the massive price collapse post-acquisition warrants scrutiny of fundamental developments between the transaction date and current market conditions.

2026-06-08
low
1,424,537 shares
$148,922
@ $0.10
Significance 3

HRT Financial LP acquired 1,424,537 shares at $0.10 avg, stock down -100.0% from 52-week high of $9300.00

HRT Financial LP executed 2 separate purchases totaling 1,424,537 shares for $148,922.04 on 2026-06-04 and 2026-06-05, bringing the 10% owner's holdings from -1,038,356 shares to 386,181 shares post-transaction. The stock has fallen -100.0% from its 52-week high and declined -92.2% over the last 30 days, suggesting acute downward pressure. Across HRT's open-market history at other tickers, prior buys averaged +59.7% return over 90 days, but at WOK specifically, the insider's 2 prior trades show mixed results: a sell on 2026-05-29 returned +4.0% and a buy on 2026-05-28 returned +15.6% over 90 days. The company's market cap stands at $1,459,194.20, indicating a micro-cap position where liquidity and volatility constraints should inform investor evaluation.

2026-06-03
medium
2,746,332 shares
$378,994
@ $0.14
Significance 4

HRT Financial LP (10% owner) bought 2,746,332 shares at $0.14 on 2026-06-01, sold 1,757,955 at $0.11 on 2026-06-02; net long 988,377 shares. Stock down 100.0% from 52-week high.

HRT Financial LP executed two separate transactions within 24 hours: a purchase of 2,746,332 shares for $378,993.82 followed by a partial sale of 1,757,955 shares for $188,101.19, leaving a net position of 988,377 shares. The pre-transaction position was -988,377 shares (short), meaning this activity closed a short position and converted it to a long position. The stock is now trading at $0.11, down 100.0% from its 52-week high of $9400.00 and down 91.9% over the last 30 days, suggesting severe distress. At the same ticker, HRT's prior two trades (a sell on 2026-05-29 and a buy on 2026-05-28) resulted in positive 90-day returns, though only 1 of 2 was characterized as well-timed at the 90-day mark. The context—extreme price deterioration, sub-penny trading range, and a micro-cap market cap of $1,605,113.62—suggests this activity may reflect forced portfolio adjustments or loss management rather than a discretionary conviction signal.

2026-06-01
high
1,535,850 shares
$138,226
@ $0.09
Significance 7

10% owner HRT Financial LP liquidates entire 1.08M share WOK stake, selling 2,619,607 shares at $0.10 after buying 1,535,850 at $0.09 on consecutive days.

HRT Financial LP executed 2 separate transactions on consecutive days: purchasing 1,535,850 shares at $0.09 on 2026-05-28 ($138,226.50) and selling 2,619,607 shares at $0.10 on 2026-05-29 ($261,960.70), reducing holdings from 1,083,757 shares to zero. The complete exit follows a period of severe price deterioration—the 52-week range of $0.09–$10800.00 indicates the stock has declined -100.0% from its 52-week high and -91.5% over 30 days. While the insider's cross-ticker track record shows strong prior buy performance (13 prior buys with 85.71% 90-day win rate, avg 90d return +649.2%), the 7 prior sells on the same track record achieved only a 33.33% well-timed rate (90-day win rate), suggesting this seller's sell-timing historically lags. The stock's current price of $0.11 and microscopic market cap of $1,605,113.62 underscores the extreme illiquidity and distress characteristics of this position liquidation.

Insiders here also file at

More Measuring and Controlling Instruments companies